• LAST PRICE
    29.8800
  • TODAY'S CHANGE (%)
    Trending Up0.4600 (1.5636%)
  • Bid / Lots
    29.4100/ 2
  • Ask / Lots
    29.8800/ 1
  • Open / Previous Close
    29.4100 / 29.4200
  • Day Range
    Low 29.4000
    High 29.8900
  • 52 Week Range
    Low 4.5850
    High 29.8900
  • Volume
    46,864
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 29.42
TimeVolumeNVCN
09:32 ET10029.41
09:34 ET110029.41
09:59 ET10029.43
10:14 ET14029.6176
10:32 ET10029.48
10:35 ET59129.5
10:37 ET62829.5
10:42 ET80029.41
10:44 ET10029.41
10:48 ET10029.43
10:50 ET20029.41
11:00 ET141329.41
11:06 ET25329.4479
11:09 ET220029.41
11:11 ET10029.4454
11:27 ET10029.45
11:45 ET10029.41
11:58 ET10029.45
12:14 ET20029.41
12:41 ET826029.52
12:48 ET29229.58
01:15 ET10029.62
01:21 ET30029.57
01:48 ET10029.6
02:04 ET20029.6
02:24 ET50029.6
02:27 ET20029.5
02:56 ET10029.58
03:18 ET161629.6
03:32 ET60029.6
03:54 ET1000029.61
03:57 ET973529.79
03:59 ET44529.88
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNVCN
Neovasc Inc
111.2M
0.0x
---
As of 2023-03-25

Company Information

Neovasc Inc. is a Canada-based specialty medical device company. The Company develops, manufactures, and markets products for the cardiovascular marketplace. The Company is engaged in the development of minimally invasive therapies in cardiovascular care: refractory angina and mitral valve regurgitation. Its products include the Neovasc Reducer (Reducer), for the treatment of refractory angina, and the Tiara (Tiara), for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe. The Company operates through one business segment: the development, manufacturing and marketing of medical devices. The Company's subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc. The Company carries its business in Canada, the United States and Europe.

Contact Information

Headquarters
Richmond, 5138-13562 Maycrest WayRICHMOND, BC, Canada V6V 2J7
Phone
604-270-4344
Fax
604-270-4344

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$111.2M
Revenue (TTM)
$4.3M
Shares Outstanding
2.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.92
EPS
$-16.87
Book Value
$26.47
P/E Ratio
0.0x
Price/Sales (TTM)
26.1
Price/Cash Flow (TTM)
---
Operating Margin
-857.91%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.